Stage 5 Chronic Kidney Disease
Nephrology
Prevalence
10760.8 / 100K
Incidence
273.3 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| rayaldee | REPLIGEN CORP (RGEN) |
Frequently asked questions
How many drugs are in development for Stage 5 Chronic Kidney Disease?
BioSniper tracks 1 drug in development for Stage 5 Chronic Kidney Disease across 1 company.
How many clinical trials target Stage 5 Chronic Kidney Disease?
There are 1 clinical trial targeting Stage 5 Chronic Kidney Disease tracked by BioSniper.
What is the prevalence of Stage 5 Chronic Kidney Disease?
The estimated prevalence of Stage 5 Chronic Kidney Disease is approximately 10760.8 per 100,000 population.
Deep-dive into Stage 5 Chronic Kidney Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis